SCHEMBL6169738

SCHEMBL6169738

CC1(c2ccc(Oc3ccccc3)cc2)NC(=S)N(c2ccc(O)cc2)C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 2/20 0.43
LTA4H P09960 1/20 0.42
NR1H2 P55055 1/20 0.42
BAX Q07812 1/20 0.42
MGLL Q99685 1/20 0.42
MMP2 P08253 1/20 0.41
MMP3 P08254 1/20 0.41
MMP9 P14780 1/20 0.41
MMP8 P22894 1/20 0.41
MMP13 P45452 1/20 0.41
GAA P10253 2/20 0.41
KDM4E B2RXH2 1/20 0.41
GFER P55789 1/20 0.41
AR P10275 1/20 0.41
BRD4 O60885 1/20 0.40
LMNA P02545 1/20 0.39
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6167711 0.92 CNR1 (0.50) CNR1MGLLMMP2MMP3MMP9
SCHEMBL6169535 0.91 HSD17B3 (0.45) LTA4HMGLLGAAARLMNA
SCHEMBL6168870 0.89 GAA (0.46) CNR1LTA4HMGLLMMP2MMP3
SCHEMBL6168079 0.85 LMNA (0.47) CNR1MGLLMMP2MMP3MMP9
SCHEMBL6168712 0.85 CNR1 (0.46) CNR1MGLLMMP2MMP3MMP9
SCHEMBL6168455 0.81 PGR (0.41) CNR1MGLLMMP2MMP3MMP9
SCHEMBL6167462 0.81 CNR1 (0.41) CNR1MGLLMMP2MMP3MMP9
SCHEMBL6170632 0.80 ALDH1A1 (0.46) MMP13GAAALDH1A1HTT
SCHEMBL7481341 0.79 CNR1 (0.55) CNR1GAAKDM4ELMNAALDH1A1
SCHEMBL6170930 0.79 HSD11B1 (0.44) MGLLGAAKDM4ELMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546111-A2 2-THIOHYDANTOINE DERIVATIVE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF DIABETES LABORATOIRES FOURNIER S.A. (FR) 2005-06-29 EP disclosed
WO-2004031160-A2 2-THIOHYDANTOINE DERIVATIVE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF DIABETES LABORATOIRES FOURNIER S.A. (FR) 2004-04-15 WO disclosed